Compare CSTL & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSTL | AHRT |
|---|---|---|
| Founded | 2007 | 1979 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 611.1M | 501.3M |
| IPO Year | 2019 | 2013 |
| Metric | CSTL | AHRT |
|---|---|---|
| Price | $21.16 | $6.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $45.50 | $7.00 |
| AVG Volume (30 Days) | 468.8K | ★ 901.1K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 9.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $344,229,000.00 | N/A |
| Revenue This Year | $2.42 | $854.92 |
| Revenue Next Year | $12.69 | $11.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $14.59 | $5.13 |
| 52 Week High | $44.28 | $6.98 |
| Indicator | CSTL | AHRT |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 68.05 |
| Support Level | $17.72 | $5.93 |
| Resistance Level | $24.46 | N/A |
| Average True Range (ATR) | 1.12 | 0.17 |
| MACD | 0.37 | 0.01 |
| Stochastic Oscillator | 74.65 | 78.46 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.